Schedule 13G ownership disclosure

Terns Pharmaceuticals Inc

Security class unavailable · CUSIP: 880881107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,120,865
Percent of class
4.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001086364-24-007820
Form type
SC 13G/A
Filer
BlackRock Finance, Inc.
CIK
CIK 1364742
Filed
Jun 07, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G/A | SEC Filings Hub